These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Anti-obesity and hypolipidemic effects of Rheum undulatum in high-fat diet-fed C57BL/6 mice through protein tyrosine phosphatase 1B inhibition. Lee W; Yoon G; Hwang YR; Kim YK; Kim SN BMB Rep; 2012 Mar; 45(3):141-6. PubMed ID: 22449699 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571. Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011 [TBL] [Abstract][Full Text] [Related]
24. Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus. Panzhinskiy E; Ren J; Nair S Curr Med Chem; 2013; 20(21):2609-25. PubMed ID: 23627940 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B. He HB; Gao LX; Deng QF; Ma WP; Tang CL; Qiu WW; Tang J; Li JY; Li J; Yang F Bioorg Med Chem Lett; 2012 Dec; 22(23):7237-42. PubMed ID: 23067554 [TBL] [Abstract][Full Text] [Related]
26. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice. Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170 [TBL] [Abstract][Full Text] [Related]
27. Furanoterpenes, new types of protein tyrosine phosphatase 1B inhibitors, from two Indonesian marine sponges, Ircinia and Spongia spp. Abdjul DB; Yamazaki H; Kanno SI; Wewengkang DS; Rotinsulu H; Sumilat DA; Ukai K; Kapojos MM; Namikoshi M Bioorg Med Chem Lett; 2017 Mar; 27(5):1159-1161. PubMed ID: 28189419 [TBL] [Abstract][Full Text] [Related]
29. Dammaranes from Gynostemma pentaphyllum and synthesis of their derivatives as inhibitors of protein tyrosine phosphatase 1B. Xu JQ; Shen Q; Li J; Hu LH Bioorg Med Chem; 2010 Jun; 18(11):3934-9. PubMed ID: 20472439 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of IKK-beta: a new development in the mechanism of the anti-obesity effects of PTP1B inhibitors SA18 and SA32. Bhattarai BR; Ko JH; Shrestha S; Kafle B; Cho H; Kang JH; Cho H Bioorg Med Chem Lett; 2010 Feb; 20(3):1075-7. PubMed ID: 20044255 [TBL] [Abstract][Full Text] [Related]
31. Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age. Morrison CD; White CL; Wang Z; Lee SY; Lawrence DS; Cefalu WT; Zhang ZY; Gettys TW Endocrinology; 2007 Jan; 148(1):433-40. PubMed ID: 17038557 [TBL] [Abstract][Full Text] [Related]
32. 4-Quinolone-3-carboxylic acids as cell-permeable inhibitors of protein tyrosine phosphatase 1B. Zhi Y; Gao LX; Jin Y; Tang CL; Li JY; Li J; Long YQ Bioorg Med Chem; 2014 Jul; 22(14):3670-83. PubMed ID: 24906513 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity mice. Ito M; Fukuda S; Sakata S; Morinaga H; Ohta T J Diabetes Res; 2014; 2014():680348. PubMed ID: 24987707 [TBL] [Abstract][Full Text] [Related]
34. Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling. Erbe DV; Klaman LD; Wilson DP; Wan ZK; Kirincich SJ; Will S; Xu X; Kung L; Wang S; Tam S; Lee J; Tobin JF Diabetes Obes Metab; 2009 Jun; 11(6):579-88. PubMed ID: 19383031 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors. Sun LP; Ma WP; Gao LX; Yang LL; Quan YC; Li J; Piao HR J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1199-204. PubMed ID: 23009604 [TBL] [Abstract][Full Text] [Related]
36. Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors. Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Joharapurkar A; Dhanesha N; Shaikh M; Sairam KV; Kapadnis P Bioorg Med Chem Lett; 2012 Jan; 22(2):1111-7. PubMed ID: 22189136 [TBL] [Abstract][Full Text] [Related]
37. Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B. Gomez E; Vercauteren M; Kurtz B; Ouvrard-Pascaud A; Mulder P; Henry JP; Besnier M; Waget A; Hooft Van Huijsduijnen R; Tremblay ML; Burcelin R; Thuillez C; Richard V J Mol Cell Cardiol; 2012 Jun; 52(6):1257-64. PubMed ID: 22446161 [TBL] [Abstract][Full Text] [Related]
38. Isoxazol-5(4H)one derivatives as PTP1B inhibitors showing an anti-obesity effect. Kafle B; Aher NG; Khadka D; Park H; Cho H Chem Asian J; 2011 Aug; 6(8):2073-9. PubMed ID: 21656690 [TBL] [Abstract][Full Text] [Related]
39. The design strategy of selective PTP1B inhibitors over TCPTP. Li X; Wang L; Shi D Bioorg Med Chem; 2016 Aug; 24(16):3343-52. PubMed ID: 27353889 [TBL] [Abstract][Full Text] [Related]
40. Protein tyrosine phosphatase 1B inhibitors for diabetes. Johnson TO; Ermolieff J; Jirousek MR Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]